Clinical trial
Pioglitazone Treatment for Insulin Resistant Patients With Mood Disorders
NCT01559857 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pioglitazone Treatment for Insulin Resistant Patients With Mood Disorders
- Lead sponsor
- Stanford University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- June 30, 2014
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.